Literature DB >> 11459871

Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.

M J Stoutjesdijk1, C Boetes, G J Jager, L Beex, P Bult, J H Hendriks, R J Laheij, L Massuger, L E van Die, T Wobbes, J O Barentsz.   

Abstract

BACKGROUND: Although breast cancer screening is recommended to start at a younger age for women with a hereditary risk of breast cancer, the sensitivity of mammography for these women is reduced. We compared magnetic resonance imaging (MRI) with mammography to determine which is more sensitive and whether MRI could play a role in the early detection of breast cancer for these women.
METHODS: We constructed a retrospective cohort of all breast MRI and mammography surveillance reports made in our department from November 1994 to February 2001. All of the 179 women in the cohort had received biannual palpation in addition to annual imaging by MRI, mammography, or both. The 258 MRI images and the 262 mammograms were classified with the use of the BI-RADS (i.e., Breast Imaging Reporting and Data System) scoring system, which has five categories to indicate the level of suspicion of a lesion. Receiver operator characteristic curves were generated for MRI and mammography, and the area under each curve (AUC) was assessed for the entire cohort of 179 women and for a subset of 75 women who had received both an MRI and a mammographic examination within a 4-month period. All statistical tests were two-sided.
RESULTS: In the cohort of 179 women, we detected 13 breast cancers. Seven cancers were not revealed by mammography, but all were detected by MRI. For the entire cohort, the AUC for mammography was 0.74 (95% confidence interval [CI] = 0.68 to 0.79), and the AUC for MRI was 0.99 (95% CI = 0.98 to 1.0). For the subset of women who had both examinations, the AUC for mammography was 0.70 (95% CI = 0.60 to 0.80), and the AUC for MRI was 0.98 (95% CI = 0.95 to 1.0).
CONCLUSION: MRI was more accurate than mammography in annual breast cancer surveillance of women with a hereditary risk of breast cancer. Larger prospective studies to examine the role of MRI in screening programs are justified.

Entities:  

Mesh:

Year:  2001        PMID: 11459871     DOI: 10.1093/jnci/93.14.1095

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  49 in total

Review 1.  Pearls and pitfalls in breast MRI.

Authors:  I Millet; E Pages; D Hoa; S Merigeaud; F Curros Doyon; X Prat; P Taourel
Journal:  Br J Radiol       Date:  2011-11-29       Impact factor: 3.039

2.  Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.

Authors:  Janie M Lee; Pamela M McMahon; Chung Y Kong; Daniel B Kopans; Paula D Ryan; Elissa M Ozanne; Elkan F Halpern; G Scott Gazelle
Journal:  Radiology       Date:  2010-03       Impact factor: 11.105

3.  [Clip marker placement following MR-guided vacuum biopsy of the breast].

Authors:  C Perlet; H Sittek; M Reiser; S H Heywang-Köbrunner
Journal:  Radiologe       Date:  2005-03       Impact factor: 0.635

4.  Power spectral analysis of mammographic parenchymal patterns for breast cancer risk assessment.

Authors:  Hui Li; Maryellen L Giger; Olufunmilayo I Olopade; Michael R Chinander
Journal:  J Digit Imaging       Date:  2008-01-03       Impact factor: 4.056

5.  Integration of microwave tomography with magnetic resonance for improved breast imaging.

Authors:  Paul M Meaney; Amir H Golnabi; Neil R Epstein; Shireen D Geimer; Margaret W Fanning; John B Weaver; Keith D Paulsen
Journal:  Med Phys       Date:  2013-10       Impact factor: 4.071

Review 6.  Incorporating new imaging models in breast cancer management.

Authors:  Denise H Reddy; Ellen B Mendelson
Journal:  Curr Treat Options Oncol       Date:  2005-03

7.  Molecular Imaging in Breast Cancer - Potential Future Aspects.

Authors:  Katja Pinker; Wolfgang Bogner; Stephan Gruber; Peter Brader; Siegfried Trattnig; Georgios Karanikas; Thomas H Helbich
Journal:  Breast Care (Basel)       Date:  2011-04-29       Impact factor: 2.860

Review 8.  Breast cancer imaging: a perspective for the next decade.

Authors:  Andrew Karellas; Srinivasan Vedantham
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

9.  The significance of circumscribed malignant mammographic masses in the surveillance of BRCA 1/2 gene mutation carriers.

Authors:  R Kaas; R Kroger; J H C L Hendriks; A P E Besnard; W Koops; F A Pameijer; W Prevoo; C E Loo; S H Muller
Journal:  Eur Radiol       Date:  2004-04-09       Impact factor: 5.315

Review 10.  Screening for breast cancer.

Authors:  Joann G Elmore; Katrina Armstrong; Constance D Lehman; Suzanne W Fletcher
Journal:  JAMA       Date:  2005-03-09       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.